MERIT CRO’s Post

This final guidance is intended to assist industry in the design and analysis of studies that assess the influence of impaired renal function on the pharmacokinetics and/or pharmacodynamics of an investigational drug and addresses how such information can inform product labeling. #pharmacokinetics #drugdevelopment #pharmacodynamics #regulatoryscience #labeling

Key Concepts in RLT: Therapeutic Index Want to improve your understanding of RLT? Watch our video below on the importance of therapeutic index to drug development. #Healthcare #Radiopharmaceuticals

Dosimetry guided radiopharmaceutical therapy can help maximize the therapeutic index!

SDxLabs offers industry-leading 2-day result turnaround time for clinical phenotyping services. Our quick turnaround time helps keep clinical trials moving while minimizing costs, especially when compared to other labs with turnaround times ranging from 7-10 days. Learn more about how SDxLabs can support your clinical drug trial: #clinicaltrials #pharmacogenetics

How drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for #healthcareproviders and improved access to therapy for the patients they serve🖋️Suzanne Shelley (she/her) #pharmaceuticalindustry #pharma #realworldevidence #realworlddata

Excitement is soaring as we plunge into 2024, with a wave of innovative trials that demand our attention. #clinicaltrials #biotech #pharma #medicaldevice https://lnkd.in/gXsz6Qv5

Clinical trials often face delays, and in a competitive industry, where time-to-market is everything, keeping these delays to a minimum could be the difference between a market-leading product and one destined for the shadows. McKinsey calculates that a second-to-market product will have a 6% market share disadvantage ten years later, showing the long-lasting impact a delay could have. In the next in this series of articles by Ian Hoban, Business Development Director at Abacus Medicine Pharma Services, titled “Solving clinical trial delays: Three things to do now,” Ian discusses some methods to help avoid and manage trial delays. The full article can be reached via this link -  https://bit.ly/3rYn9cG #pharma #clinicaltrialsolutions #commercialpartnerships #AMPS